Notable Put Options Activity in Keryx Biopharmaceuticalskerx
Shares of Keryx Biopharmaceuticals (NASDAQ: KERX) are higher on the session by 2.90%, currently trading at $3.19. The stock has been moving largely higher over the past two months and is currently trading above the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the February 2012 $3.00 put, which has traded 4,500 times on open interest of 4,538 contracts.
Put volume is outpacing call volume by 6 to 1.
Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.